Suppr超能文献

术后上颌窦癌患者调强放射治疗与三维适形放射治疗的疗效比较。

Treatment outcomes of intensity-modulated radiotherapy versus 3D conformal radiotherapy for patients with maxillary sinus cancer in the postoperative setting.

作者信息

Suh Yang-Gun, Lee Chang Geol, Kim Hyunju, Choi Eun Chang, Kim Se Hun, Kim Chang-Hoon, Keum Ki Chang

机构信息

Department of Radiation Oncology, Yonsei University College of Medicine, Seoul, Republic of Korea.

Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, Republic of Korea.

出版信息

Head Neck. 2016 Apr;38 Suppl 1:E207-13. doi: 10.1002/hed.23971. Epub 2015 Jun 4.

Abstract

BACKGROUND

In this study, we compared the treatment outcomes of postoperative 3D conformal radiotherapy (RT) and intensity-modulated radiotherapy (IMRT) for patients with maxillary sinus carcinoma.

METHODS

Fifty-four patients underwent surgery and postoperative RT, of whom 27 (50%) had squamous cell carcinoma and 14 (26%) had adenoid cystic carcinoma. Nineteen patients (35%) were treated with IMRT and 35 patients (65%) received 3D conformal RT. The median radiation dose for 3D conformal RT and IMRT were 62.1 and 63 Gy, respectively.

RESULTS

IMRT produced significantly superior radiation dose distribution to planning target volumes (PTVs) than 3D conformal RT. Over a median follow-up of 60 months, IMRT provided better 3-year locoregional recurrence-free survival (89.2% vs 59.5%; p = .035) and distant metastasis-free survival (94.7% vs 55.3%; p = .042) rates than 3D conformal RT.

CONCLUSION

Postoperative IMRT for patients with maxillary sinus carcinoma resulted in excellent disease control, and should be considered as the first treatment option in these cases. © 2015 Wiley Periodicals, Inc. Head Neck 38: E207-E213, 2016.

摘要

背景

在本研究中,我们比较了上颌窦癌患者术后三维适形放疗(3D-CRT)和调强放疗(IMRT)的治疗效果。

方法

54例患者接受了手术及术后放疗,其中27例(50%)为鳞状细胞癌,14例(26%)为腺样囊性癌。19例(35%)患者接受调强放疗,35例(65%)患者接受三维适形放疗。三维适形放疗和调强放疗的中位放射剂量分别为62.1 Gy和63 Gy。

结果

与三维适形放疗相比,调强放疗在计划靶区(PTV)产生的放射剂量分布明显更优。在中位随访60个月期间,调强放疗的3年局部区域无复发生存率(89.2%对59.5%;p = 0.035)和无远处转移生存率(94.7%对55.3%;p = 0.042)均优于三维适形放疗。

结论

上颌窦癌患者术后调强放疗可实现良好的疾病控制,应被视为这些病例的首选治疗方案。© 2015威利期刊公司。《头颈》38: E207-E213, 2016。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验